Eminence Capital, LP Alnylam Pharmaceuticals, Inc. Transaction History

Eminence Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $16 Million - $22.1 Million	-125,979 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $2.92 Million - $3.49 Million	23,710 Added 23.18%	125,979 $16.4 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $9.61 Million - $13.1 Million	-79,304 Reduced 43.68%	102,269 $14.9 Million
Q2 2020 Aug 17, 2020	BUY	$104.21 - $156.44 $18.9 Million - $28.4 Million	181,573 New	181,573 $26.9 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.